B. Braun Medical has launched the first Heparin 5000 USP Unit/0.5mL prefilled syringe with an attached safety needle for subcutaneous and intravenous use in the US.
The prefilled syringe is equipped with a “label-integrated Schreiner MediPharm Needle-Trap system that, upon activation, guards against accidental needle stick injuries,” said Leigh Nickens, Director of Marketing, Fluid Therapy and Injectable Drugs at B. Braun. It is preservative-free and has 24-month stability at room temperature.
Heparin Sodium Injection is indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism (PE), prevention of postoperative deep venous thrombosis and PE in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease, atrial fibrillation with embolization, treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation), prevention of clotting in arterial and cardiac surgery, prophylaxis and treatment of peripheral arterial embolism, anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.
For more information visit bbraunusa.com
This article originally appeared on MPR